Search
for
Sort by
Research 211–240 of 1000+
- JAK inhibitors for alopecia areata: a systematic review and meta‐analysis
- Topical tofacitinib for patients with lichen planopilaris and/or frontal fibrosing alopecia
- Cedrol from Platycladus orientalis (L.) Franco regulates M1/M2 polarization of macrophages and promotes hair regeneration
- Activity‐based therapeutic algorithm for folliculitis decalvans: A practical tool for effective management
- Jak inhibitors in the treatment of alopecia areata - a literature review
- Alopecia Universalis: Never Give Up?
- Prescribing patterns amongst UK dermatologists for the treatment of alopecia areata, female pattern hair loss, and frontal fibrosing alopecia
- Visualizing Severity of Alopecia Tool (SALT) scores in the clinical setting using patient images from a clinical trial
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Alopecia areata – Current understanding and management
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases
- JAK1 Signaling Is Involved in the Induction of Mechanical Alloknesis in Atopic Dermatitis
- Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Results from a Survey in Five European Countries
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Alopecia universalis unresponsive to treatment with tofacinitib: report of a case with a brief review of the literature
- Janus kinase inhibitors for alopecia areata
- Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors
- Management of folliculitis decalvans: The EADV task force on hair diseases position statement
- [JAK INHIBITORS FOR THE TREATMENT OF ALOPECIA AREATA].
- Alopecia universalis after injection of messenger RNA COVID-19 vaccine. A case report
- Relapse of alopecia areata during ongoing Janus kinase inhibitor therapy is not uncommon and usually occurs in previously affected areas: A multicenter Italian real-world study
- 0527 Effectiveness of janus kinase inhibitor for rapidly progressive acute alopecia areata
- 75993 Safety of Janus kinase inhibitors for treatment of alopecia areata
- Management of Alopecia Areata through Unani Medicine
- Possible Involvement of Skin‐Resident Memory T Cells in Refractory Chronic Alopecia Areata
- Ritlecitinib in Alopecia Areata: A 24‐Week Real‐World Experience Contrasting JAK Inhibitor‐Naïve and JAK Inhibitor‐Experienced Patients
- Erythroderma, Alopecia, Anhidrosis, and Vitiligo as Complications of a Red Ink Tattoo—A Case Report
- Lichen planopilaris associated with hair extensions in a patient with alopecia areata: A case report
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review